The chimeric fusion oncogene termed as BCR-ABL is a type of leukaemia-specific fusion transcript that mainly appears in human chronic myeloid leukaemia (CML) patients. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.